| 古力巴哈提·夏米尔,张燕.适龄女性接种人乳头瘤病毒疫苗后再感染的影响因素分析.[J].中南医学科学杂志.,2025,(1):166-169. |
| 适龄女性接种人乳头瘤病毒疫苗后再感染的影响因素分析 |
| Analysis of influencing factors of reinfection after human papilloma virus vaccination in women of appropriate age |
| 投稿时间：2024-05-22 修订日期：2024-12-05 |
| DOI：10.15972/j.cnki.43-1509/r.2025.01.041 |
| 中文关键词: 适龄女性 人乳头瘤病毒 再感染 影响因素 [ |
| 英文关键词:female of appropriate age human papilloma virus reinfection influencing factor |
| 基金项目:乌鲁木齐市卫健委科技计划项目(202216) |
|
| 摘要点击次数: 0 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的探究适龄女性接种人乳头瘤病毒(HPV)疫苗后再感染可能的影响因素。 方法选择预防接种HPV疫苗的适龄女性977例为研究对象,收集其基本信息、HPV感染情况。接种疫苗后随访3年,采用Cox比例风险模型分析接种HPV疫苗后再感染可能的影响因素。 结果977例适龄女性中有90例(9.21%)接种疫苗后HPV检测为阳性。适龄女性接种HPV疫苗后,HPV感染率随检测年份呈现上升趋势(P＜0.05)。多因素Cox回归分析表明,年龄偏大、多性伴和疫苗接种前感染高危型HPV是疫苗接种后再感染的危险因素,初次性行为年龄晚是疫苗接种后再感染的保护因素(P＜0.05)。 结论年龄偏大、多性伴和疫苗接种前感染高危型HPV是疫苗接种后再感染的危险因素,初次性行为年龄晚是疫苗接种后再感染的保护因素。 |
| 英文摘要: |
| AimTo explore the possible influencing factors of reinfection after human papilloma virus (HPV) vaccination in women of appropriate age. Methods977 women of appropriate age who received HPV vaccination were used as subjects, and their basic information and HPV infection rate were collected. These women were followed up for 3 years, and Cox proportional risk model was used to analyze the possible influencing factors of reinfection after HPV vaccination. ResultsAmong 977 women of appropriate age, 90 (9.21) cases were positive for HPV after vaccination. The positive rate of HPV, the positive rate of vaccine and the infection rate of high-risk type of vaccine showed an increasing trend with years (P＜0.05). Multivariate Cox regression analysis showed that older age, multiple sexual partners and pre-vaccination infection of high-risk HPV were risk factors for post-vaccination reinfection, and late age of first sexual intercourse was a protective factor for post-vaccination reinfection (P＜0.05). ConclusionOlder age, multiple sexual partners and pre-vaccination infection of high-risk HPV are risk factors for post-vaccination reinfection, and late age of first sexual intercourse is protective factor for post-vaccination reinfection. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |